Abstract Submission

• All abstracts must be written in English in a non-stigmatising language.
• SIOG welcomes multiple abstracts from the same author.
• Make sure to use an active email address that you will be able to access regularly for communication with the Scientific Secretariat. For convenience reasons, you will be requested to use the same email address when registering for the conference to facilitate your identification.
• The majority of accepted abstracts will be assigned to posters. A limited number of abstracts will be accepted as oral presentations in Rapid Fire and Plenary Abstract sessions.
• Abstracts can only be submitted online through the dedicated online system. Abstracts sent as email attachments will not be considered.
• It is the submitter’s responsibility to review the list of co-authors before submitting the abstract. No amendment will be accepted after the submission deadline.
• Define all abbreviations in your abstract at first use.
• Always make sure to check the final abstract with the system’s preview function before submission, and edit or replace as necessary.
• It is the author’s responsibility to submit a correct abstract. Please ensure your abstract does not contain spelling, grammar, or scientific mistakes, as it will be reproduced exactly as submitted. Linguistic accuracy is your responsibility. No proofreading will be done.
• The submitting author is required to ensure that all co-authors and the presenting author are aware of the content of the abstract before submission of the abstract.

With the submission of an abstract to the SIOG 2024 Annual Conference, the submitting author:

• Accepts responsibility for the accuracy of the submitted abstract.
• Confirms that all authors are aware of and agree to the content of the abstract and support the data presented.
• Warrants that the data and conclusions presented in the abstract have not been published in the same format and with the same title prior to the date of the conference.
• Identifies any financial interest in products or processes described in the abstract. This information is to be forwarded to the Scientific Programme Committee together with the abstract.
• States that, for studies involving human or animal subjects, permission has been obtained from the relevant regulatory authority and properly informed consent given where appropriate.
• Accepted abstracts will be published online as a supplement of the Journal of Geriatric Oncology (JGO). The authors give permission for the abstract, when selected for presentation (oral or poster), to be published online by SIOG on the conference website and in any Journal Supplement for this conference.

IMPORTANT: To have an accepted abstract published in the official journal, the presenting author must be registered to the conference by 24 July 2024.

• A main track that is relevant to your abstract must be selected during the submission process. The Scientific Programme Committee reserves the right to change the track during the abstract assessment process.

• Track 1:Clinical trials and precision medicine in older adults with cancer

This track focuses on clinical trials (drug and non-drug), imaging studies, and other precision approaches).

• Track 2:Biology and epidemiology in cancer and aging

This track includes fundamental biology of cancer, epidemiology, and prognostic studies.

• Track 3:Strategies and health services research to improve outcomes of diverse populations of older adults with cancer and their caregivers

This track relates to studies describing or attempting to address disparities and gaps in the care of diverse populations of older adults with cancer and/or caregivers. This track also includes health services research including but not limited to cost-effectiveness and decision-making evaluations in diverse populations of older adults with cancer and their caregivers.

• Track 4:Supportive care delivery in older adults with cancer and their caregivers

This track includes geriatric assessment implementation studies, models of care, and other areas of supportive and palliative care throughout the cancer journey for patients and caregivers.

• Track 5:Education to improve geriatric oncology knowledge and practice

This track includes educational scholarship at all levels with an aim to improve awareness of or ability to better care for older adults with cancer, and educational initiatives targeting researchers, caregivers, patients, patient partners and clinicians.

You have the possibility to submit your abstract to be considered for the Young SIOG Investigator Award and the Nursing and Allied Health Investigator Award. Please do not forget to select the option while submitting your abstract. (Only members of SIOG are eligible for these awards.)  Please ensure that you have an active membership before submitting your abstract if you would like to apply for these awards. Membership is not required to submit an abstract, but a multitude of benefits are offered to SIOG members (access to the presentations at the close of the conference for instance). To learn more and join, please click here.

Please find listed below the eligibility criteria for the Nursing and Allied Health Investigator Award and the Young SIOG Investigator Award

Note: Application to the Nursing and Allied Health Investigator Award is open to nurses, pharmacists, occupational and physical therapists, social workers and other non-physician health professionals and PhD researchers.

Note: Application to the Young SIOG Investigator Award is open to Junior experts in the field of geriatric oncology (with less than ten (10) years post exit from formal training programme)

Working as a trainee in any discipline that is related to the treatment of older cancer patients (e.g. surgery, radiotherapy, medical oncology, urology, pulmonology, haematology) and / or PhD student, postdoctoral fellow or researcher

• If your abstract is accepted as a poster, you will be requested to be available for discussion during the corresponding poster viewing session.

Format and technical specifications

To be considered for review, an abstract should comply with the following guidelines and respect the below structure:

• Abstract text should not exceed 1700 characters, spaces included.
• The maximum number of characters for the title of the abstract, spaces excluded, is 200.
• Authors’ names, institutions and keywords are not included in this limit.
• A maximum of 2 graphs, images or tables is allowed per abstract. The maximum file size of each figure/image is 5 MB whereas the maximum pixel size of the figure/image is 600(w) x 800(h) pixels. Tables cannot be bigger than 10 rows x 10 columns. The data and figures in these items will not be considered for the word count.
• Capitals should be used only for the initial of the first word, acronyms and proper nouns.

The abstract needs to be structured as follows:

• Introduction: this section should contain 1-2 sentences that clearly indicate the scientific question of the study and its clinical (or other) importance
• Objective: this section points to what the result of your study will be
• Methods: this section should contain sufficient information to be able to understand the experimental design, the analytical techniques and the statistics used in the study
• Results: this section should contain objective data to answer the scientific question(s)
• Conclusions: this section should provide only conclusions of the study directly supported by the results, along with implications for clinical practice, avoiding speculation and overgeneralization

Only the structural heading should be in bold letters (Introduction, Objective, Methods, Results, Conclusion).

You can start an abstract and decide to finalise it at a later stage before the submission deadline by clicking on the “Save” button. Once you have completed the online submission, please click on the “Submit” button for the actual submission of the abstract.  The abstracts not duly submitted by 25 April at 11:59pm CEST will not be considered for review.

The corresponding author will receive a confirmation by email of the successful submission of their abstract. Authors should not consider their abstract as submitted if they have not received any email confirmation, and they are invited to contact siog-scientific@kit-group.org.

Submitting an abstract for SIOG 2024 Annual Conference does not constitute registration for the conference. Abstract presenters must register by 24 July 2024 to attend by following the instructions for registration on the SIOG 2024 Annual Conference website.

Note: Abstracts of authors failing to comply with the registration deadline will not be included in the electronic Abstract Book of the conference published as a Supplement of the Journal of Geriatric Oncology (JGO). Authors registering at a later stage will still be allowed to attend and present by interacting with the participants visiting the Poster Area and responding to their questions.

For questions regarding the online submission process, please contact siog-scientific@kit-group.org.

All abstract submitters will be notified in June 2024 of the status of their abstract.